Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in the world, and has no radical treatment. Inhibition of amiloride-sensitive epithelial sodium ion channel (ENaC) has now been considered as a potential therapeutic target against COPD. One possible modulator of ENaC...

Description complète

Détails bibliographiques

Auteurs principaux:	Ryunosuke Nakashima, Hirofumi Nohara, Noriki Takahashi, Aoi Nasu, Megumi Hayashi, Tomoki Kishimoto, Shunsuke Kamei, Haruka Fujikawa, Kasumi Maruta, Taisei Kawakami, Yuka Eto, Keiko Ueno-Shuto, Mary Ann Suico, Hirofumi Kai, Tsuyoshi Shuto
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2022-06-01
Collection:	Journal of Pharmacological Sciences
Sujets:	Chronic obstructive pulmonary disease (COPD) Epithelial Na+ channel (ENaC) Metformin AMP-Activated protein kinase (AMPK)
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S1347861322000226
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!